Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chinese Health Insurance Ruralization Expands Patient Pool For Clinical Trials

This article was originally published in PharmAsia News

Executive Summary

SAN FRANCISCO - China's plan to expand health insurance plans to rural areas will greatly increase access to patients for clinical trials, in turn driving market growth as more companies look to enroll patients in China, according to panelists discussing clinical trials in Asia at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference in San Francisco

You may also be interested in...



NovaMed CEO Mark Lotter On Working With Pharma Distributors In China: An Interview With PharmAsia News

Shanghai-based NovaMed Pharmaceuticals was founded in August 2005 to provide distribution services for multinational pharmaceutical companies in China. NovaMed has signed China deals with several multinationals, including Baxter, Pfizer and Sanofi-Aventis. NovaMed Founder and CEO Mark Lotter recently participated in an email interview with PharmAsia News' Shanghai bureau about the changing contours of the pharmaceutical sector in China.

NovaMed CEO Mark Lotter On Working With Pharma Distributors In China: An Interview With PharmAsia News

Shanghai-based NovaMed Pharmaceuticals was founded in August 2005 to provide distribution services for multinational pharmaceutical companies in China. NovaMed has signed China deals with several multinationals, including Baxter, Pfizer and Sanofi-Aventis. NovaMed Founder and CEO Mark Lotter recently participated in an email interview with PharmAsia News' Shanghai bureau about the changing contours of the pharmaceutical sector in China.

Accelovance’s Stephen Trevisan And Robert deGroof On China’s Clinical Research Landscape: An Interview With PharmAsia News (Part 2 of 2)  

[Editor's Note: This is part two of a two-part interview. Part one appeared in PharmAsia News, May 15, 2008.]

Latest News
UsernamePublicRestriction

Register

SC068146

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel